Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Baxter International Inc (BAX) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

Baxter International IncTrade
Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Baxter International Inc vs Citius Pharmaceuticals Inc — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.27B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Baxter International Inc is far larger — about 713.1× Citius Pharmaceuticals Inc's market cap, and Baxter International Inc pays a 0.14% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

BAXCTXR
Market Cap
$14.27B$20.01M
Sector
HealthHealth
52-Week High
$28.35$1.82
52-Week Low
$15.80$0.48
Enterprise Value
$21.79B$16.23M
Dividend Yield
0.14%

Returns comparison

Trailing returns across standard periods

About Baxter International Inc

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.

Read more on BAX

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR